With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...
In the current market session, Regeneron Pharmaceuticals Inc. REGN share price is at $695.58, after a 0.06% decrease. Over the past month, the stock spiked by 2.93%, but over the past year, it ...
Zacks.com on MSN23h
Pharma Stock Roundup: EU Nod to MRK's Welireg, IONS' Q4 Results & MoreThis week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback